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This study examined the effects of ascorbic acid on the
attenuation of an ischemia-reperfusion (I/R) injury after a
canine renal transplantation. Eight beagle dogs were
subjected to a renal auto-transplantation followed by the
administration of ascorbic acid (treatment group) and the
same amount of vehicle (physiological saline, control
group). Blood samples were collected from these dogs to
perform the kidney function tests and the invasive blood
pressure was measured in the renal artery at pre- and
post- anastomosis. The antioxidant enzymes of level 72 h
after the transplant were measured. The kidneys were
taken for a histopathology evaluation at day 21. The
kidney function tests showed a significant difference
between the control and treatment group. The invasive
blood pressure in the renal artery was similar in the
groups. The activity of the antioxidant enzymes in the
blood plasma was significant lower in the control group
than in the treatment group. The histopathology findings
revealed the treatment group to have less damage than the
control group. The results of this study suggest that
ascorbic acid alone might play a role in attenuating I/R
injury and assist in the recovery of the renal function in a
renal transplantation model.
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Introduction
Kidney transplantation is the ideal treatment for chronic
renal failure and various end-stage renal diseases [4,13,20].
The viability of the transplanted organ depends its ability to
tolerate cold and warm ischemia and reperfusion during
surgery [6,10]. Ischemia-reperfusion injury is a major cause
of renal failure and renal graft rejection. Therefore, reducing
the extent of this injury in renal transplant patients is
important for achieving a good prognosis.
Renal ischemia-reperfusion (I/R) injury leads to the
production of excess reactive oxygen species (ROS) and
reactive nitrogen species (RNS). These species cause oxidative
stress resulting in alterations in the level of mitochondrial
oxidative phosphorylation, ATP depletion, increases in the
intracellular calcium and activation of protein kinases,
phosphatases, proteases, lipases and nucleases leading to a
loss of cellular function and integrity [21]. Therefore, it is
important to reduce the levels of these hazardous metabolites
in order to improve the patient’s outcome.
In order to reduce these metabolites, many studies have
examined a variety of free radical oxygen scavengers. These
include the effects of external supplementation of antioxidants
[3,8,12,13] and the activities of endogenous enzymatic
antioxidant defense system in a kidney ischemia/reperfusion
injury [2,7]. Ascorbic acid has been used to protect against
corneal damage by free radicals in rabbits [19]. In addition,
it has also been used to improve the renal hemodynamics as
well as decreased oxidative stress, inflammation and fibrosis
in the ischemic kidney of pigs [5]. Ascorbic acid is an
inexpensive low-priced antioxidant that can be administered
easily as it is water-soluble. This study investigated of the
ability of ascorbic acid as free radical oxygen scavenger to
attenuate ischemia-reperfusion injury and the recovery of
the renal function in a canine renal autograft model. 
Materials and Methods
Animals and experimental groups
Adult beagle dogs of both genders, weighing 10-13 kg
(Marshal Farms, USA) were used in this study. The animals
were acclimatized and maintained on a standard diet, a
routine lighting cycle and room temperature for 6 months,
and had a normal renal function before the surgical
procedure. The dogs were assigned randomly into a control
group (n = 4) and ascorbic acid treatment group (n = 4).
Kidney harvest
The left kidney was freed from the perirenal tissue and fat,
and the left renal artery and vein were then clamped using an
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atraumatic vascular clamp. The ligation and resection of the
vessels was performed at the aorta and caudal vena cava,
and moved to a tray filled with ice.
Flushing
After the left kidney had been removed, all the arteries in
the control group were perfused with cold normal saline.
Cold normal saline and ascorbic acid (100 mg/kg; Dai Han
Pharm, Korea) were perfused in the treatment group
followed by autotransplantation.
Transplantation
After an overnight fast, the animals are premedicated with
atropine sulfate (0.04 mg/kg, SC; Huons, Korea), and an
antibiotic prophylaxis with cefazolin sodium (20 mg/kg, IV;
Chong Kun Dang, Korea) and an analgesic with meloxicam
(0.2 mg/kg, IV; Boehringer Ingelheim, Korea) were
administered at induction. The animals were induced with
thiopental sodium (12.5 mg/kg, IV; Dai Han Pharm, Korea)
and maintained with isoflurane 2% and a 100% oxygen
supply during the procedure. All the dogs were administered
a balanced electrolyte solution (10 ml/kg/h, IV). The dogs
were administered mannitol (1 g/kg, IV; Dai Han Pharm,
Korea) 20 min before the nephrectomies. The kidneys were
exposed through a midline incision, and the left renal artery,
vein, and ureter were mobilized for transplantation. The
kidneys were harvested, flushed with a cold, heparinized
saline solution, and placed in a cold, sterile saline solution
before the anastomosis. The renal vein was anastomosis to
the caudal vena cava in an end-to-side manner using a
simple continuous suture pattern of 6-0 polypropylene. The
renal artery was anastomosed to the external iliac artery in
an end-to-end manner using 7-0 polypropylene in a simple
interrupted pattern. If 2 renal arteries were present, both
arteries were managed with a bridging of the renal arteries
using a modification of the technique reported by Sarin et al.
[20]. The ureter was sutured to the bladder mucosa in a
modified ureteroneocystostomy technique using 5-0
polyglyconate in a simple interrupted pattern. A nephropexy
was created by suturing the renal capsule to the abdominal
wall with simple interrupted sutures made from 4-0
polyglycolic acid. After implanting the autograft, contralateral
kidneys were removed. Postoperatively, all the dogs were
allowed access to water and food ad libitum.
Three days after surgery, vitamin C (30 mg/kg) was
injected intravenously in treatment group with the same
amount of vehicle (physiological saline solution) being
injected in the control group.
Renal function
The blood urea nitrogen (BUN) and creatinine levels were
determined from the serum samples taken on days 0, 1, 3, 5,
and 7 before and after the procedure from the jugular vein,
using a commercially available kit (VetTest; IDEXX,
Japan). The results are expressed in milligrams per deciliter.
Blood Pressure
The invasive blood pressure was measured using Pulscan-
Component (Scionic, USA) and a monitoring-set was used
for the arterial blood pressure measurement (B/Braun,
Germany) at the renal and external iliac arteries. The blood
pressure was measured at pre-anastomosis, 10 and 60 min
after the anastomosis through a direct invasion using a 24 G
scalp vein set (Korea Vaccine, Korea) in the lumen of the
artery.
Antioxidant enzyme activity in plasma
Blood samples were collected using an anticoagulant as
EDTA, and centrifuged at 700~1,000 × g for 10 min at 4
oC.
The samples were then pipetted off the top yellow plasma
layer without disturbing the buff layer, and the plasma
samples were stored on ice until assayed or were freeze at
−80
oC. The superoxide dismutase  (SOD) activity was
determined using a commercial SOD assay kit (Cayman,
USA) for measuring the SOD activity from the plasma. The
activity was recorded spectrophotometrically at 450 nm.
The enzyme activity was calculated as U/ml. The glutathione
peroxidase  (GSHPx) activity was measured using a
commercial GSHPx assay kit (Cayman, USA). The activity
was recorded spectrophotometrically at 340 nm. The catalase
(CAT) activity was measured spectrophotometrically at 540
nm using a commercial CAT assay kit (Cayman, USA).
Histopathological examination
The study protocol called for euthanizing the surviving
canines after the third post-transplant week if the serum
creatinine values had normalized to <1.8 mg/dl. The tissue
samples from the left kidney were taken for a histology
examination after euthanasia on postoperative day 21. The
tissue samples were fixed in 10% neutral buffered formalin,
embedded in paraffin, sectioned in 4 µm slices, and
mounted on slides. After deparaffinizing, each specimen
was stained with hematoxylin and eosin for an optical
microscopy examination. The morphological characteristics
of the kidneys were determined using a blinded histology
examination.
Statistical analysis
All the values are expressed as a means ± SD of the
determinations for all the dogs in the group. The data was
analyzed using an analysis of the variance followed by 2-
way repeated measures analysis (ANOVA) and then by a
Student’s  t-test. A p value <0.05 or 0.01 was considered
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Results
Renal function
The serum creatinine levels, which are an index of the
kidney function, increased significantly to 6.73 ± 2.12 mg/dl
in the control group (baseline levels; 0.72 ± 0.07) after 5
days of reperfusion and then decreased gradually. On the
other hand, the serum creatinine levels in the treatment
group (baseline levels; 0.87 ± 0.06) increased to 2.71 ± 1.32
mg/dl after 3 days reperfusion and then decreased gradually
by 7 days. The BUN was also measured as a second index of
the kidney function. Similar to the serum creatinine level,
the BUN levels in the control group (baseline levels; 11.7 ±
6.68) increased significantly to 176.6 ± 49.32 mg/dl by 5
days after reperfusion. The BUN levels in the treatment
group (baseline levels; 14.4 ± 1.26) increased to 59.87 ±
21.04 mg/dl after 7 days reperfusion.
Blood Pressure
The blood pressure was measured directly at the external
iliac artery. The systolic blood pressure in the control group
increased from 86.5 ± 19.67 to 98.5 ± 11.32 mmHg while in
the treatment group, these levels decreased from 86 ± 12.67
to 84.75 ± 15.32 mmHg. In the control group, the diastolic
blood pressure also increased from 77. 75 ± 18.24 to 88 ±
11.51 mmHg while these levels decreased from 78.5 ± 12.23
to 77 ± 13.83 mmHg in the treatment group. In the control
group, the mean blood pressure increased from 80.5 ± 18.92
to 91.75 ± 11.14 mmHg by 60 min after the anastomosis. In
contrast, in the treatment group, the mean blood pressure
increased to 85.5 ± 15.69 mmHg by 10 min and then decreased
gradually thereafter, and was almost normalized to 79.5 ±
14.20 mmHg by 60 min. However, there was no significant
difference between the groups.
Antioxidant enzyme activity in plasma
The antioxidant enzyme activity in the plasma after the
renal autotransplantation was evaluated. The specific SOD,
GSHPx and CAT activities before surgery and 72 h after
reperfusion are expressed as the mean ± SD. The activity of
SOD increased slightly from 2.14 ± 0.22 to 2.31 ± 0.17
nmol/min/ml in the control group. In contrast, the activity of
SOD in the treatment group increased from 2.37 ± 0.21 to
2.69 ± 0.25 nmol/min/ml by 72 h of reperfusion (p = 0.037,
Fig. 1). There was no significant change in the GSHPx
activity in the control group. On the other hand, in the
treatment group, the level of activity increased significantly
from 109.16 ± 19.51 to 132.47 ± 15.50 nmol/min/ml by 72 h
of reperfusion (p = 0.032, Fig. 2). There was no significant
change in the CAT activity in the control group whereas the
CAT activity in the treatment group increased from 2.73 ±
0.30 to 3.74 ± 0.37 nmol/min/ml by 72 h of reperfusion (p =
0.038, Fig. 3).
Histology and morphologic examination
At the autopsy 21 days after the transplant, the control
kidneys in which a normal saline had been administered
demonstrated moderate cystic dilation of the tubules along
with inflammatory cell infiltration, regeneration of the
tubules and congestion (Fig. 4A & B). In contrast, the kidneys
Fig. 1. The total plasma SOD activity after renal auto transplantatio n
followed by 72 h of reperfusion. The values are expressed as the
mean ± SD for both groups. *p < 0.05; statistical significances
between the control and treatment group.
Fig. 2. The plasma GSHPx activity after renal autotransplantatio n
followed by 72 h of reperfusion. The values are expressed as the
mean ± SD for both groups. *p < 0.05; statistical significances
for control versus treatment group.
Fig. 3. The activity of plasma CAT after renal autotransplantatio n
followed by 72 h of reperfusion. The values are expressed as
mean ± SD for both groups. *p < 0.05; statistical significances
between the control and treatment group.378 Jae-il Lee et al.
in the treatment group, which had been administered
ascorbic acid after the renal transplantation showed slight
damage to the tubules. The tubular epithelium was essentially
normal, even though there was occasional, mild cystic
dilation of tubules with mild peritubular inflammatory cell
infiltration and regeneration of the tubules (Fig. 4C & D).
Discussion
Oxidative stress is an imbalance between oxidants such as
ROS and antioxidants [22], and probably contributes to the
development, progression, and complications of both acute
renal and chronic renal failure, which is characterized by the
increased production or decreased elimination of antioxidants
[1,9,15,23,25]. Ascorbic acid reduces the level of reactive
oxidant species both intracellularly and extracellularly, and
maintains transition metals in their reduced form. In
addition, ascorbic acid may quench the free radical
intermediates of the carcinogen metabolism. Ascorbic acid
is an outstandingly powerful antioxidant that reacts rapidly
with a variety of oxidants, including the rather poorly
reactive superoxide anion radical [11].
These results suggest that the levels of various antioxidant
enzymes (SOD, GSHPx, and CAT) levels, which protect
against oxygen free radicals, were higher in the ascorbic
acid treated group. Generally, the conversion of the
superoxide anion and hydrogen peroxide was impaired due
to the decreased levels of SOD, GSHPx and CAT, resulting
in an increase in the level of oxygen free radicals [16].
Therefore, the elevated superoxide and hydrogen peroxide
levels accelerate the damage to the kidney. However,
ascorbic acid as an antioxidant detoxified the hydrogen
peroxide produced. In this study, ascorbic acid as an
exogenous antioxidant appeared to attenuate I/R injury by
increasing the activities of SOD, GSHPx, and CAT. On the
other hand, the concentration of antioxidant enzymes
increased due to a decrease in their consumption rather than
decreased as a result of another scavenger.
In this study, although the invasive blood pressure was
similar in both groups, the levels in the treatment group had
almost normalized by 60 min after the transplant. There is
evidence suggesting that vitamin C may affect the intracellular
levels of glutathione, which can improve flow-mediated,
endothelium-dependent dilation [29]. Ascorbic acid is a
potent aqueous phase antioxidant that has been shown to
improve the endothelial dysfunction as a result of an
interaction between endothelium-derived NO and ROS [14,
26,27]. Although the NO concentration was not measured in
this study, it is believed that ascorbic acid can increased the
quantity of NO under these conditions.
Bilateral multiple renal arteries were encountered during
surgery. According to the literature, approximately 15% of
humans have bilateral multiple renal arteries [18]. In this
study, 37% of the dogs had double arteries, and all were
different sized parallel vessels. Therefore, the technique of
bridging the renal arteries was used in this study, and at
autopsy, no complications from the arterial stenosis were
observed. However, the possibility that multiple renal
arteries could have affected the clinical outcomes cannot be
excluded. Therefore, a study using more cases as well as a
long-term follow-up will be needed.
The histology and morphological examination showed
less damage to the tubules in the treatment group than in the
control group. It has been reported that an inflammatory
response induced by ischemia followed by reperfusion is
largely responsible for the tissue damage observed [24,28].
In this study, an inflammatory response demonstrated slight
damage to the tubules in the treatment group. Although
irreversible damage of tubular system was observed in some
dogs in both groups, it is unclear if it was due to surgical
problems or to the effects of ascorbic acid. Therefore,
further study with more samples will be needed. Although
these results cannot explain the entire mechanism for the
attenuation of ischemia-reperfusion injury, the results of the
functional parameters, histopathological changes, antioxidant
enzyme activity suggest that ascorbic acid alone may play a
role in attenuating ischemia-reperfusion injury and assist in
the recovery of the renal function after a renal transplant.
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Fig. 4. Microphotographs of the control group (A, B) and
ascorbic acid treatment group (C, D). A; Showing partial loss o f
the lining cells and cystic dilation of the tubules. B; Medulla r
tubules showed focal apical or loss of apical cytoplasm. C;
Showing mild regeneration of the tubular system. D; Tubula r
system of the medulla showing a normal cellular integrity. H&E
stain, A, B, C; ×200, D; ×100.Attenuation of renal ischemia-reperfusion injury by ascorbic acid 379
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